Exome Asset Management
Finance · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
444 Madison Ave Ste 39A, New York City, ...Phone Number
(212) 403-3900Website
www.exomeasset.comRevenue
<$5 MillionIndustry
ZI Rank: 2
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
2
2
2
1
2
About Exome Asset Management
Exome Asset Management is an innovative asset management firm based in New York City, specializing in investments within the global healthcare industry. The company focuses on identifying the best and most innovative healthcare investments across various subsectors, including pharmaceuticals, biotech, medical devices, and healthcare services. Exome employs two main investment strategies, targeting both developed markets, particularly the United States, and emerging markets. With a diverse team led by experienced healthcare fund manager Samuel D. Isaly, Exome is committed to investing for a healthier world.Explore more
Exome Asset Management Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Exome Asset Management your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Exome Asset Management is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Exome Asset Management
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Exome Asset Management launches new products
Earning: See what the market has to say on Exome Asset Management recently announced quarterly report
Funding: Get notified immidiatlly once Exome Asset Management has new funding data
Website visits: Recent activity has been detected on your website
Exome Asset Management, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Exome Asset Management has recently received funding, and reach out quickly before it becomes old news!
Click to see if Exome Asset Management had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Exome Asset Management as Masked Content
Find 2 more new buyers
Compare Similar Companies to Exome Asset Management
Compare insights from companies similar to Exome Asset Management, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Exome Asset Management is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Exome Asset Management is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Exome Asset Management.
Exome Asset Management Tech Stack
A closer look at the technologies used by Exome Asset Management
Most Recent Scoops
Project
Spending/Investment, Funding
Project
Spending/Investment
Promotion
Executive Move
Promotion
Executive Move
Project
Spending/Investment
Exome Asset Management News & Media
Exome Asset Management Shortlisted for HFM’s Sector Specialist and Emerging Market Fund Awards
NEW YORK--(BUSINESS WIRE)--Exome Asset Management (“Exome”), an innovative asset management company focusing on investing in public markets across the worldwide healthcare industry, today announced it has been shortlisted for the HFM US Performance Awards 2022 for both Sector Specialist and Emerging Market Fund. The HFM US Performance Awards are one of the most important and influential awards in the US hedge fund calendar. The awards recognize hedge fund, CTA and fund of hedge fund performanceExome Invests in Impact Therapeutics’ Series D1 Financing
NEW YORK--(BUSINESS WIRE)--Exome Asset Management LLC, led by Sam Isaly, participated in the Series D1 financing of IMPACT Therapeutics, a biopharmaceutical company dedicated to the discovery and development of targeted anti-cancer therapeutics based on synthetic lethality, which recently closed. Proceeds will be used to accelerate the development of its synthetic lethality programs, many of which are showing best-in-class potential. “Synthetic lethality is one of several promising new approachExome Asset Management Shortlisted for HFM’s Best Newcomer Award
NEW YORK--(BUSINESS WIRE)--Exome Asset Management (“Exome”), an innovative asset management company focusing on investing in public markets across the worldwide healthcare industry, today announced it has been shortlisted for the HFM US Performance Awards 2021 for Best Newcomer. The HFM US Performance Awards are one of the most important and influential awards in the US hedge fund calendar. The awards recognize hedge fund, CTA and fund of hedge fund performance, encompassing the whole breadth oExome-Backed Broncus Holding Corporation Launches Hong Kong Public Offering | Business Wire
Exome Asset Management (“Exome”), an innovative asset management company focusing on investing in public markets across the worldwide healthcare indus
Read more news
Top Finance Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Exome Asset Management
Sign Up For FreeTo access detailed company insights
Exome Asset Management is an innovative asset management firm based in New York City, specializing in investments within the global healthcare industry. The company focuses on identifying the best and most innovative healthcare investments across various subsectors, including pharmaceuticals, biotech, medical devices, and healthcare services. Exome... Read More
